# US 2019/0169218 A1 · Amphipathic compound having novel penta-saccharide hydrophilic group and use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0169218 A1
- Document ID: US20190169218A1
- Status: Published application
- Kind: A1
- Application number: 16/092,938
- Filed: 2017-04-14
- Published: 2019-06-06
- Earliest claimed: 2016-04-14
- Assignees: Industry-University Cooperation Foundation Hanyang University Erica Campus
- Applicants: Industry-University Cooperation Foundation Hanyang University Erica Campus
- Inventors: Pil Seok CHAE; Muhammad EHSAN
- Web page: https://patentgrep.com/patent/US20190169218A1

## CPC

- C07H 15/04: attached to an oxygen atom of the saccharide radical
- C07K 1/14: Extraction; Separation; Purification
- G01N 33/68: involving proteins, peptides or amino acids {(involving lipoproteins G01N33/92)}
- C07K 1/145: {by extraction or solubilisation}
- C07K 1/306: {by crystallization}
- Y02P 20/55: Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- Y02P: CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

## Abstract

Disclosed are an amphipathic compound having a penta-saccharide hydrophilic group, a method of preparing the same, and a method of extracting, solubilizing, stabilizing, crystallizing or analyzing membrane proteins and membrane protein complexes using the same. In particular, since the compound has a high-density penta-saccharide hydrophilic group composed of five glucose units, the compound may have an excellent effect on crystallization of membrane proteins. In addition, since the hydrophilic group used in the amphipathic compound has a novel structure, the hydrophilic group may be applied to the development of various amphipathic molecules.

## Claims

### Claim 1

A compound represented by Formula 1 below:
wherein L represents a substituted or unsubstituted C1-C10 alkylene group, or a direct bond;
A1 and A2 represent methylene groups or oxygen atoms;
each of R1 and R2 independently represents a substituted or unsubstituted C3-C20 alkyl group, a substituted or unsubstituted C3-C20 cycloalkyl group, or a substituted or unsubstituted C3-C20 aryl group;
X represents a glucose-centered branched penta-saccharide linked by oxygen; and
Z represents a hydrogen atom or —CH2-A3-R3, wherein A3 represents a methylene group or an oxygen atom, and R3 independently represents a substituted or unsubstituted C3-C20 alkyl group, a substituted or unsubstituted C3-C20 cycloalkyl group, or a substituted or unsubstituted C3-C20 aryl group.

### Claim 2 (depends on 1)

The compound according to claim 1, wherein L represents a methylene group; A1 and A2 represent methylene groups; each of R1 and R2 independently represents a substituted or unsubstituted C3-C20 alkyl group, a substituted or unsubstituted C3-C20 cycloalkyl group, or a substituted or unsubstituted C3-C20 aryl group; and Z represents a hydrogen atom.

### Claim 3 (depends on 1)

The compound according to claim 1, wherein L represents a methylene group; A1 and A2 represent methylene groups; R1 and R2 represent substituted or unsubstituted C5-C15 alkyl groups; R1 and R2 are the same; and Z represents a hydrogen atom.

### Claim 4 (depends on 1)

The compound according to claim 1, wherein L represents a direct bond; A1 and A2 represent oxygen atoms; each of R1 and R2 independently represents a substituted or unsubstituted C3-C20 alkyl group, a substituted or unsubstituted C3-C20 cycloalkyl group, or a substituted or unsubstituted C3-C20 aryl group; and Z represents a hydrogen atom.

### Claim 5 (depends on 1)

The compound according to claim 1, wherein L represents a direct bond; A1 and A2 represent oxygen atoms; R1 and R2 represent substituted or unsubstituted C5-C15 alkyl groups; R1 and R2 are the same; and Z represents a hydrogen atom.

### Claim 6 (depends on 1)

The compound according to claim 1, wherein L represents a methylene group; and Z represents —CH2-A3-R3, wherein one or more of A1 to A3 represent oxygen atoms and the other(s) represent(s) methylene groups; each of R1 to R3 independently represents a substituted or unsubstituted C3-C20 alkyl group, a substituted or unsubstituted C3-C20 cycloalkyl group, or a substituted or unsubstituted C3-C20 aryl group; and R1 to R3 are the same.

### Claim 7 (depends on 1)

The compound according to claim 1, wherein L represents a methylene group; and Z represents —CH2-A3-R3, wherein one or more of A1 to A3 represent oxygen atoms and the other(s) represent(s) methylene groups; each of R1 to R3 independently represents a substituted or unsubstituted C3-C20 alkyl group; and R1 to R3 are the same.

### Claim 8 (depends on 1)

The compound according to claim 1, wherein the compound is represented by one of Formulas 2 to 18 below:

### Claim 9 (depends on 1)

The compound according to claim 1, wherein the compound is an amphipathic molecule for extracting, solubilizing, stabilizing, crystallizing or analyzing membrane proteins.

### Claim 10 (depends on 1)

The compound according to claim 1, wherein the compound has a critical micelle concentration (CMC) of 0.0001 to 0.1 mM in an aqueous solution.

### Claim 11 (depends on 1)

A composition for extracting, solubilizing, stabilizing, crystallizing or analyzing membrane proteins, comprising the compound according to claim 1.

### Claim 12 (depends on 11)

The composition according to claim 11, wherein the composition is prepared in a form of micelles, liposomes, emulsions or nanoparticles.

### Claim 13

A method of preparing a compound represented by Formula 1 below, the method comprising:
preparing dialkylated diethylmalonate by adding a 1-iodoalkane to diethyl malonate;
preparing a dialkylated mono-ol by adding LiCl, DMSO and H2O to the prepared dialkylated diethylmalonate, heating the mixture to a temperature of 150 to 200° C., and adding LiAlH4 and THF to the mixture;
introducing a protecting group-attached glucose by performing a glycosylation reaction on the prepared dialkylated mono-ol;
removing an O-benzoyl group by performing a deprotection reaction on the product prepared in the introducing;
attaching four glucose units with attached protecting groups by performing a glycosylation reaction on the product prepared in the removing to introduce a penta-saccharide hydrophilic group; and
removing an O-benzoyl group by performing a deprotection reaction on the product prepared in the attaching,
wherein L represents a methylene group; A1 and A2 represent methylene groups; each of R1 and R2 independently represents a substituted or unsubstituted C3-C20 alkyl group, a substituted or unsubstituted C3-C20 cycloalkyl group, or a substituted or unsubstituted C3-C20 aryl group; Z represents a hydrogen atom; and X represents a glucose-centered branched penta-saccharide.

### Claim 14

A method of preparing a compound represented by Formula 1 below, the method comprising:
preparing an alcohol derivative by adding NaOH and an alcohol to epichlorohydrin;
introducing a protecting group-attached glucose by performing a glycosylation reaction on the prepared alcohol derivative;
removing an O-benzoyl group by performing a deprotection reaction on the product prepared in the introducing;
attaching four glucose units with attached protecting groups by performing a glycosylation reaction on the product prepared in the removing to introduce a penta-saccharide hydrophilic group: and
removing an O-benzoyl group by performing a deprotection reaction on the product prepared in the attaching,
wherein L represents a direct bond; A1 and A2 represent oxygen atoms; each of R1 and R2 independently represents a substituted or unsubstituted C3-C20 alkyl group, a substituted or unsubstituted C3-C20 cycloalkyl group, or a substituted or unsubstituted C3-C20 aryl group; Z represents a hydrogen atom; and X represents a glucose-centered branched penta-saccharide.

### Claim 15

A method of preparing a compound represented by Formula 1 below, comprising:
preparing dialkylated diethylmalonate by adding a 1-iodoalkane to diethyl malonate;
preparing a dialkylated diol by adding LiAlH4 and THF to the prepared dialkylated diethylmalonate;
adding an alkyl chain by adding a 1-bromoalkane to the prepared dialkylated diol;
introducing a protecting group-attached glucose by performing a glycosylation reaction on the product prepared in the adding;
removing an O-benzoyl group by performing a deprotection reaction on the product prepared in the introducing;
attaching four glucose units with attached protecting groups by performing a glycosylation reaction on the product prepared in the removing to introduce a penta-saccharide hydrophilic group; and
removing an O-benzoyl group by performing a deprotection reaction on the product prepared in the attaching,
wherein L represents a methylene group; Z represents —CH2-A3-R3, wherein one of A1 to A3 represents an oxygen atom and the others represent methylene groups; each of R1 to R3 independently represents a substituted or unsubstituted C3-C20 alkyl group; and R1 to R3 are the same; and X represents a glucose-centered branched penta-saccharide.

### Claim 16

A method of preparing a compound represented by Formula 1 below, the method comprising:
synthesizing a dialkylated diol using 5,5-bis-bromomethyl-2,2-dimethyl-[1,3]dioxane as a starting material;
adding an alkyl chain by adding a 1-bromoalkane to the product prepared in the synthesizing;
introducing a protecting group-attached glucose by performing a glycosylation reaction on the product prepared in the adding;
removing an O-benzoyl group by performing a deprotection reaction on the product prepared in the introducing;
attaching four glucose units with attached protecting groups by performing a glycosylation reaction on the product prepared in the removing to introduce a penta-saccharide hydrophilic group; and
removing an O-benzoyl group by performing a deprotection reaction on the product prepared in the attaching,
wherein L represents a methylene group; Z represents —CH2-A3-R3, wherein A1 to A3 represent oxygen atoms; each of R1 to R3 independently represents a substituted or unsubstituted C3-C20 alkyl group; and R1 to R3 are the same; and X represents a glucose-centered branched penta-saccharide.

### Claim 17

A method of extracting, solubilizing, stabilizing, crystallizing or analyzing membrane protein, the method comprising treating membrane proteins with a compound represented by Formula 1 below in an aqueous solution:
wherein L represents a substituted or unsubstituted C1-C10 alkylene group, or a direct bond;
each of A1 and A2 represents a methylene group or an oxygen atom;
each of R1 and R2 independently represents a substituted or unsubstituted C3-C20 alkyl group, a substituted or unsubstituted C3-C20 cycloalkyl group, or a substituted or unsubstituted C3-C20 aryl group;
X represents a glucose-centered branched penta-saccharide linked by oxygen; and
Z represents a hydrogen atom or —CH2-A3-R3, wherein A3 represents a methylene group or an oxygen atom, and R3 independently represents a substituted or unsubstituted C3-C20 alkyl group, a substituted or unsubstituted C3-C20 cycloalkyl group, or a substituted or unsubstituted C3-C20 aryl group.

### Claim 18 (depends on 17)

The method according to claim 17, wherein L represents a methylene group; A1 and A2 represent methylene groups; each of R1 and R2 independently represents a substituted or unsubstituted C3-C20 alkyl group, a substituted or unsubstituted C3-C20 cycloalkyl group, or a substituted or unsubstituted C3-C20 aryl group; and Z represents a hydrogen atom.

### Claim 19 (depends on 17)

The method according to claim 17, wherein L represents a direct bond; A1 and A2 represent oxygen atoms; each of R1 and R2 independently represents a substituted or unsubstituted C3-C20 alkyl group, a substituted or unsubstituted C3-C20 cycloalkyl group, or a substituted or unsubstituted C3-C20 aryl group; and Z represents a hydrogen atom.

### Claim 20 (depends on 17)

The method according to claim 17, wherein L represents a methylene group; and Z represents —CH2-A3-R3, wherein one or more of A1 to A3 represent oxygen atoms and the other(s) represent(s) methylene groups; each of R1 to R3 independently represents a substituted or unsubstituted C3-C20 alkyl group, a substituted or unsubstituted C3-C20 cycloalkyl group, or a substituted or unsubstituted C3-C20 aryl group; and R1 to R3 are the same.

### Claim 21 (depends on 17)

The method according to claim 17, wherein the membrane proteins are boron transporter (BOR1), leucine transporter (LeuT), melibiose permease (MelB), human β2 adrenergic receptors (β2ARs), uric acid-xanthine/H+ symporter (UapA), or a combination of two or more thereof.
